Sathe Nila, Andrews Jeffrey C, McPheeters Melissa L, Warren Zachary E
Departments of Health Policy.
Vanderbilt Evidence-based Practice Center, Institute for Medicine and Public Health, Vanderbilt University Medical Center, Nashville, Tennessee.
Pediatrics. 2017 Jun;139(6). doi: 10.1542/peds.2017-0346.
Children with autism spectrum disorder (ASD) frequently use special diets or receive nutritional supplements to treat ASD symptoms.
Our objective was to evaluate the effectiveness and safety of dietary interventions or nutritional supplements in ASD.
Databases, including Medline and PsycINFO.
Two investigators independently screened studies against predetermined criteria.
One investigator extracted data with review by a second investigator. Investigators independently assessed the risk of bias and strength of evidence (SOE) (ie, confidence in the estimate of effects).
Nineteen randomized controlled trials (RCTs), 4 with a low risk of bias, evaluated supplements or variations of the gluten/casein-free diet and other dietary approaches. Populations, interventions, and outcomes varied. Ω-3 supplementation did not affect challenging behaviors and was associated with minimal harms (low SOE). Two RCTs of different digestive enzymes reported mixed effects on symptom severity (insufficient SOE). Studies of other supplements (methyl B, levocarnitine) reported some improvements in symptom severity (insufficient SOE). Studies evaluating gluten/casein-free diets reported some parent-rated improvements in communication and challenging behaviors; however, data were inadequate to make conclusions about the body of evidence (insufficient SOE). Studies of gluten- or casein-containing challenge foods reported no effects on behavior or gastrointestinal symptoms with challenge foods (insufficient SOE); 1 RCT reported no effects of camel's milk on ASD severity (insufficient SOE). Harms were disparate.
Studies were small and short-term, and there were few fully categorized populations or concomitant interventions.
There is little evidence to support the use of nutritional supplements or dietary therapies for children with ASD.
自闭症谱系障碍(ASD)患儿经常采用特殊饮食或服用营养补充剂来治疗ASD症状。
我们的目的是评估饮食干预或营养补充剂对ASD的有效性和安全性。
数据库,包括Medline和PsycINFO。
两名研究人员根据预定标准独立筛选研究。
一名研究人员提取数据,由另一名研究人员进行审核。研究人员独立评估偏倚风险和证据强度(SOE)(即对效应估计的置信度)。
19项随机对照试验(RCT),其中4项偏倚风险较低,评估了补充剂或无麸质/无酪蛋白饮食及其他饮食方法的变体。研究人群、干预措施和结果各不相同。补充ω-3对挑战性行为没有影响,且危害极小(证据强度低)。两项关于不同消化酶的RCT报告了对症状严重程度的混合效应(证据不足)。其他补充剂(甲基B、左卡尼汀)的研究报告症状严重程度有一些改善(证据不足)。评估无麸质/无酪蛋白饮食的研究报告家长评定在沟通和挑战性行为方面有一些改善;然而,数据不足以对证据主体得出结论(证据不足)。关于含麸质或酪蛋白激发食物的研究报告激发食物对行为或胃肠道症状没有影响(证据不足);一项RCT报告骆驼奶对ASD严重程度没有影响(证据不足)。危害各不相同。
研究规模小且为短期,完全分类的人群或伴随干预措施很少。
几乎没有证据支持对ASD患儿使用营养补充剂或饮食疗法。